Yingying Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yingying Li has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Yao Wu
School of Nursing, Guangdong Pharmaceutical University, Guangzhou, China
3 shared publicationsLi Zhuo
Guangdong Geriatrics Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2 shared publicationsRuohong He
School of Nursing, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China
2 shared publications- Aihong Wang
Peking-University-Shenzhen-Hospital, Shenzhen, Guangdong, China
1 shared publication - Caixia Li
The Department of Nursing, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China
1 shared publication - Chaoqun Ma
School of Nursing, Guangdong Pharmaceutical University, Guangzhou 510310, China
1 shared publication
Latest Publications
- Open Access
- 21 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2207
Prediction Models for Postoperative Delirium Among Cancer Patients: A Scoping Review
Objectives: To systematically map postoperative delirium (POD) prediction models in cancer patients, focusing on study design, modeling methods, performance evaluation, and reporting standards. Methods: Following the Arksey and O’Malley framework and PRISMA-ScR guidelines, nine databases were searched from inception to 24 April 2026. Studies developing or validating POD prediction models in cancer patients were included and narratively synthesized. Results: Thirty-two studies conducted in China, South Korea, the United States, the Netherlands, and Japan were included, most of which had a high risk of bias. POD incidence ranged from 6.70% to 46.39%. The Confusion Assessment Method was the most common assessment tool, and logistic regression was the predominant modeling approach. The most frequently identified predictor domains were age, operation/anesthesia time, preoperative nutritional indicators, preoperative inflammatory indicators, and American Society of Anesthesiologists physical status classification. AUC values ranged from 0.690 to 0.973, and C-index values ranged from 0.783 to 0.963. However, 43.75% of studies only evaluated performance in the development dataset, 25.00% conducted external validation, and 43.75% did not assess clinical utility. Although 87.50% of studies visually presented models, interpretability analyses for machine-learning models were insufficient. Conclusions: Existing POD prediction models for cancer patients show promising discrimination, but their readiness for routine clinical use remains limited by insufficient external validation, inconsistent clinical utility assessment, and incomplete model transparency. These models should currently be regarded as risk stratification tools rather than definitive clinical decision aids. Future studies should prioritize standardized reporting, multicenter external validation, model updating, and decision-curve analysis to support safe clinical translation.
- 21 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2207
Open AccessPrediction Models for Postoperative Delirium Among Cancer Patients: A Scoping Review
Objectives: To systematically map postoperative delirium (POD) prediction models in cancer patients, focusing on study design, modeling methods, performance evaluation, and reporting standards. Methods: Following the Arksey and O’Malley framework and PRISMA-ScR guidelines, nine databases were searched from inception to 24 April 2026. Studies developing or validating POD prediction models in cancer patients were included and narratively synthesized. Results: Thirty-two studies conducted in China, South Korea, the United States, the Netherlands, and Japan were included, most of which had a high risk of bias. POD incidence ranged from 6.70% to 46.39%. The Confusion Assessment Method was the most common assessment tool, and logistic regression was the predominant modeling approach. The most frequently identified predictor domains were age, operation/anesthesia time, preoperative nutritional indicators, preoperative inflammatory indicators, and American Society of Anesthesiologists physical status classification. AUC values ranged from 0.690 to 0.973, and C-index values ranged from 0.783 to 0.963. However, 43.75% of studies only evaluated performance in the development dataset, 25.00% conducted external validation, and 43.75% did not assess clinical utility. Although 87.50% of studies visually presented models, interpretability analyses for machine-learning models were insufficient. Conclusions: Existing POD prediction models for cancer patients show promising discrimination, but their readiness for routine clinical use remains limited by insufficient external validation, inconsistent clinical utility assessment, and incomplete model transparency. These models should currently be regarded as risk stratification tools rather than definitive clinical decision aids. Future studies should prioritize standardized reporting, multicenter external validation, model updating, and decision-curve analysis to support safe clinical translation.
- Open Access
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 16, 1608552
Association between recurrence risk perception and health behavior in patients with recurrent ischemic stroke in China: the mediation effect of self-efficacy
Background: This study aims to explore the relationship between recurrence risk perception and health behavior in patients with recurrent ischemic stroke, and the mediating effect of self-efficacy between recurrence risk perception and health behavior.Method: This cross-sectional study was conducted from May 2023 to November 2023 in China on 280 recurrent ischemic stroke patients. Data on sociodemographic and clinical characteristics, the Recurrence Risk Perception Scale for Stroke Patients (RRPS-SP), the General Self-Efficacy Scale (GSES), and the Health behavior Scale of Stroke Patient (HBS-SP) were included in this study.Result: There were 266 valid questionnaires (95% effective recovery rate). In correlation analysis, high recurrence risk perception and high self-efficacy were significantly associated with better levels of health behavior (P < 0.05). In the multiple linear regression model, after controlling for sociodemographic variables and clinical characteristics information in the t/F test (P < 0.05), it was found that recurrence risk perception and self-efficacy were significant predictors of health behavior, and that exercise status, Course of Disease, and family history of stroke in the sociodemographic and clinical characteristics information in the present study had a significant effect on health behavior (P < 0.05). Self-efficacy partially mediated the relationship between recurrence risk perception and health behavior (95% CI 0.102 to 0.334), with the mediating effect accounting for 37.3% (0.202/0.541)of the total effect.Conclusion: Recurrence risk perception and self-efficacy were influential factors in promoting health behavior. In addition, the effect of recurrence risk perception on health behavior was mediated by self-efficacy.
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 16, 1608552
Open AccessAssociation between recurrence risk perception and health behavior in patients with recurrent ischemic stroke in China: the mediation effect of self-efficacy
Background: This study aims to explore the relationship between recurrence risk perception and health behavior in patients with recurrent ischemic stroke, and the mediating effect of self-efficacy between recurrence risk perception and health behavior.Method: This cross-sectional study was conducted from May 2023 to November 2023 in China on 280 recurrent ischemic stroke patients. Data on sociodemographic and clinical characteristics, the Recurrence Risk Perception Scale for Stroke Patients (RRPS-SP), the General Self-Efficacy Scale (GSES), and the Health behavior Scale of Stroke Patient (HBS-SP) were included in this study.Result: There were 266 valid questionnaires (95% effective recovery rate). In correlation analysis, high recurrence risk perception and high self-efficacy were significantly associated with better levels of health behavior (P < 0.05). In the multiple linear regression model, after controlling for sociodemographic variables and clinical characteristics information in the t/F test (P < 0.05), it was found that recurrence risk perception and self-efficacy were significant predictors of health behavior, and that exercise status, Course of Disease, and family history of stroke in the sociodemographic and clinical characteristics information in the present study had a significant effect on health behavior (P < 0.05). Self-efficacy partially mediated the relationship between recurrence risk perception and health behavior (95% CI 0.102 to 0.334), with the mediating effect accounting for 37.3% (0.202/0.541)of the total effect.Conclusion: Recurrence risk perception and self-efficacy were influential factors in promoting health behavior. In addition, the effect of recurrence risk perception on health behavior was mediated by self-efficacy.
- Open Access
- 16 September 2025
- Published by Frontiers Media SA in Frontiers in Radiology
- Vol. 5, 1634165
The evolution of artificial intelligence technology in non-alcoholic fatty liver disease
Background: The incidence of Non-alcoholic Fatty Liver Disease (NAFLD) continues to rise, becoming one of the major causes of chronic liver disease globally and posing significant challenges to healthcare systems worldwide. Artificial intelligence (AI) technology, as an emerging tool, is gradually being integrated into clinical practice for NAFLD, providing innovative approaches to improve diagnostic efficiency, personalized treatment plans, and disease prognosis assessment. However, current research remains fragmented, lacking systematic and comprehensive analysis.Objective: This study conducts a bibliometric analysis of artificial intelligence applications in Non-alcoholic Fatty Liver Disease (NAFLD), aiming to identify research trends, highlight key areas, and provide comprehensive and objective insights into the current state of research in this field. We expect that these research results will provide valuable references for guiding further research directions and promoting the effective application of AI in liver disease healthcare.Methods: This study used the Web of Science Core Collection database as the data source, searching the Science Citation Index Expanded (SCI-Expanded) and Current Chemical Reactions (CCR-Expanded) citation indexes. The search timeframe was set to include all relevant literature from 2010 to March 25, 2025. The research methodology adopted a multi-software joint analysis strategy: First, HistCite Pro 2.1 was used to analyze the historical evolution and citation relationships of literature in this field. The tables generated by the tool systematically recorded the development process of the literature, clearly depicting the evolution of the research field over time. Second, Scimago Graphica was used to create a country/region collaboration network view, intuitively showing academic collaboration among countries/regions (SCImago Lab, 2022). VOSviewer 1.6.20 was used to analyze collaboration networks and visualize keyword co-occurrences to identify main research themes and clusters. CiteSpace was used for deeper scientific literature analysis, precisely capturing the dynamic changes of research hotspots and the evolution of frontier trends through Burst Detection algorithms and Timezone View.Results: A total of 655 papers were retrieved from 60 countries, 1462 research institutions, and 4,744 authors published in 279 journals. The number of papers surged dramatically during 2019–2024, with papers from these six years accounting for approximately 83.8% (549/655) of the total. Country-level analysis showed that the United States and China are the major contributors to this field; journal analysis indicated that Scientific Reports and Diagnostics are the journals with the highest publication volumes. In-depth analysis of 655 publications revealed four major research clusters: non-invasive assessment methods for liver fibrosis, imaging-based diagnosis (magnetic resonance imaging, CT, and ultrasound), disease progression prediction model construction, and biomarker screening genes. Recent research trends indicate that deep learning algorithms and multimodal data fusion have become research hotspots in AI applications for NAFLD diagnosis and treatment. Particularly, MRI-based liver fat quantification and fibrosis assessment, combined with deep learning technologies for non-invasive diagnostic methods, show potential to replace liver biopsy.Conclusion: This study comprehensively outlines the development trajectory and knowledge structure of artificial intelligence technology in NAFLD research through systematic bibliometric analysis. The findings suggest that although the field faces challenges such as data standardization and model interpretability, AI technology shows broad prospects in NAFLD disease management and risk prediction. Future research should focus on multimodal data fusion, clinical translation, and evaluation of practical application value to promote the realization of AI-assisted precision medicine for NAFLD. This study not only depicts the current landscape of artificial intelligence applications in NAFLD but also provides a reference basis for future development in this field.
- 16 September 2025
- Published by Frontiers Media SA in Frontiers in Radiology
- Vol. 5, 1634165
Open AccessThe evolution of artificial intelligence technology in non-alcoholic fatty liver disease
Background: The incidence of Non-alcoholic Fatty Liver Disease (NAFLD) continues to rise, becoming one of the major causes of chronic liver disease globally and posing significant challenges to healthcare systems worldwide. Artificial intelligence (AI) technology, as an emerging tool, is gradually being integrated into clinical practice for NAFLD, providing innovative approaches to improve diagnostic efficiency, personalized treatment plans, and disease prognosis assessment. However, current research remains fragmented, lacking systematic and comprehensive analysis.Objective: This study conducts a bibliometric analysis of artificial intelligence applications in Non-alcoholic Fatty Liver Disease (NAFLD), aiming to identify research trends, highlight key areas, and provide comprehensive and objective insights into the current state of research in this field. We expect that these research results will provide valuable references for guiding further research directions and promoting the effective application of AI in liver disease healthcare.Methods: This study used the Web of Science Core Collection database as the data source, searching the Science Citation Index Expanded (SCI-Expanded) and Current Chemical Reactions (CCR-Expanded) citation indexes. The search timeframe was set to include all relevant literature from 2010 to March 25, 2025. The research methodology adopted a multi-software joint analysis strategy: First, HistCite Pro 2.1 was used to analyze the historical evolution and citation relationships of literature in this field. The tables generated by the tool systematically recorded the development process of the literature, clearly depicting the evolution of the research field over time. Second, Scimago Graphica was used to create a country/region collaboration network view, intuitively showing academic collaboration among countries/regions (SCImago Lab, 2022). VOSviewer 1.6.20 was used to analyze collaboration networks and visualize keyword co-occurrences to identify main research themes and clusters. CiteSpace was used for deeper scientific literature analysis, precisely capturing the dynamic changes of research hotspots and the evolution of frontier trends through Burst Detection algorithms and Timezone View.Results: A total of 655 papers were retrieved from 60 countries, 1462 research institutions, and 4,744 authors published in 279 journals. The number of papers surged dramatically during 2019–2024, with papers from these six years accounting for approximately 83.8% (549/655) of the total. Country-level analysis showed that the United States and China are the major contributors to this field; journal analysis indicated that Scientific Reports and Diagnostics are the journals with the highest publication volumes. In-depth analysis of 655 publications revealed four major research clusters: non-invasive assessment methods for liver fibrosis, imaging-based diagnosis (magnetic resonance imaging, CT, and ultrasound), disease progression prediction model construction, and biomarker screening genes. Recent research trends indicate that deep learning algorithms and multimodal data fusion have become research hotspots in AI applications for NAFLD diagnosis and treatment. Particularly, MRI-based liver fat quantification and fibrosis assessment, combined with deep learning technologies for non-invasive diagnostic methods, show potential to replace liver biopsy.Conclusion: This study comprehensively outlines the development trajectory and knowledge structure of artificial intelligence technology in NAFLD research through systematic bibliometric analysis. The findings suggest that although the field faces challenges such as data standardization and model interpretability, AI technology shows broad prospects in NAFLD disease management and risk prediction. Future research should focus on multimodal data fusion, clinical translation, and evaluation of practical application value to promote the realization of AI-assisted precision medicine for NAFLD. This study not only depicts the current landscape of artificial intelligence applications in NAFLD but also provides a reference basis for future development in this field.
- Open Access
- 4 September 2025
- Published by Elsevier in Asian Nursing Research
- Vol. 19 (5) , 442-452
Latent Profile Analysis and Influencing Factors of Learned Helplessness in Maintenance Hemodialysis Patients: A Cross-sectional Study
- 4 September 2025
- Published by Elsevier in Asian Nursing Research
- Vol. 19 (5) , 442-452
Open AccessLatent Profile Analysis and Influencing Factors of Learned Helplessness in Maintenance Hemodialysis Patients: A Cross-sectional Study
- Open Access
- 12 March 2024
- Published by Springer Nature in Research Square
Crizotinib promotes the occurrence of inferior vena cava thrombosis and pulmonary embolism in cold-exposed mice by affecting endothelial cells and macrophages
Background Despite reports of pulmonary embolism (PE) as a major adverse effect of Crizotinib, the underlying mechanisms remain unclear. This study investigated the pro-thrombotic effects of Crizotinib in mice and its cellular impact. Methods Mice underwent inferior vena cava(IVC )ligation or carrageenan-induced tail thrombosis with Crizotinib treatment. Thrombosis incidence and pathology were assessed. In vitro, Crizotinib's effects on human umbilical vein endothelial cell (HUVEC) survival, apoptosis, and permeability, and macrophage polarization and phagocytosis were evaluated. Results Crizotinib can cause IVC thrombosis in mice undergoing laparotomy sham surgery. In the Balb/c mouse IVC and tail thrombosis model induced with carrageenan injection, Crizotinib demonstrated an inflammation-independent thrombopromoting effect. In vivo studies in different strains of mice at an ambient temperature of 18°C (but not 25°C) confirmed that Crizotinib has the effect of promoting IVC thrombosis and PE. Mechanistically, Crizotinib induced HUVEC apoptosis and decreased their survival, compromising the endothelial barrier. Additionally, Crizotinib inhibited macrophage polarization and phagocytosis. Conclusion Crizotinib significantly increases thrombosis in mice, likely due to its detrimental effects on endothelial barrier integrity and macrophage function, highlighting potential mechanisms for its clinical association with PE.
- 12 March 2024
- Published by Springer Nature in Research Square
Open AccessCrizotinib promotes the occurrence of inferior vena cava thrombosis and pulmonary embolism in cold-exposed mice by affecting endothelial cells and macrophages
Background Despite reports of pulmonary embolism (PE) as a major adverse effect of Crizotinib, the underlying mechanisms remain unclear. This study investigated the pro-thrombotic effects of Crizotinib in mice and its cellular impact. Methods Mice underwent inferior vena cava(IVC )ligation or carrageenan-induced tail thrombosis with Crizotinib treatment. Thrombosis incidence and pathology were assessed. In vitro, Crizotinib's effects on human umbilical vein endothelial cell (HUVEC) survival, apoptosis, and permeability, and macrophage polarization and phagocytosis were evaluated. Results Crizotinib can cause IVC thrombosis in mice undergoing laparotomy sham surgery. In the Balb/c mouse IVC and tail thrombosis model induced with carrageenan injection, Crizotinib demonstrated an inflammation-independent thrombopromoting effect. In vivo studies in different strains of mice at an ambient temperature of 18°C (but not 25°C) confirmed that Crizotinib has the effect of promoting IVC thrombosis and PE. Mechanistically, Crizotinib induced HUVEC apoptosis and decreased their survival, compromising the endothelial barrier. Additionally, Crizotinib inhibited macrophage polarization and phagocytosis. Conclusion Crizotinib significantly increases thrombosis in mice, likely due to its detrimental effects on endothelial barrier integrity and macrophage function, highlighting potential mechanisms for its clinical association with PE.